|
US6858614B2
(en)
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenolic guanidine sodium channel blockers
|
|
US6858615B2
(en)
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenyl guanidine sodium channel blockers
|
|
US6903105B2
(en)
|
2003-02-19 |
2005-06-07 |
Parion Sciences, Inc. |
Sodium channel blockers
|
|
CA2534568A1
(en)
|
2003-08-18 |
2005-03-24 |
Parion Sciences, Inc. |
Aliphatic pyrazinoylguanidine sodium channel blockers
|
|
EP1670474A4
(en)
|
2003-08-18 |
2008-08-06 |
Parion Sciences Inc |
CYCLIC PYRAZINOYLGUANIDINE AS SODIUM CHANNEL BLOCKER
|
|
US20050090505A1
(en)
|
2003-08-18 |
2005-04-28 |
Johnson Michael R. |
Methods of reducing risk of infection from pathogens
|
|
AU2004266704B2
(en)
|
2003-08-18 |
2012-02-23 |
Parion Sciences, Inc. |
Capped pyrazinoylguanidine sodium channel blockers
|
|
US7745442B2
(en)
|
2003-08-20 |
2010-06-29 |
Parion Sciences, Inc. |
Methods of reducing risk of infection from pathogens
|
|
US7399766B2
(en)
|
2004-08-18 |
2008-07-15 |
Parion Sciences, Inc. |
Soluble amide & ester pyrazinoylguanidine sodium channel blockers
|
|
US7807834B2
(en)
|
2005-08-03 |
2010-10-05 |
Parion Sciences, Inc. |
Capped pyrazinoylguanidine sodium channel blockers
|
|
GB0526240D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
US8288391B2
(en)
|
2007-04-03 |
2012-10-16 |
Parion Sciences, Inc. |
Pyrazinoylguanidine compounds for use as taste modulators
|
|
EP2332933A1
(en)
|
2007-05-07 |
2011-06-15 |
Novartis AG |
Epithelial sodium channel (ENaC) inhibitors
|
|
WO2009019506A1
(en)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Heterocyclyc sulfonamides having edg-1 antagonistic activity
|
|
BRPI0820669A2
(pt)
|
2007-12-10 |
2020-08-04 |
Novartis Ag |
compostos orgânicos
|
|
WO2009139948A1
(en)
|
2008-02-26 |
2009-11-19 |
Johnson Michael R |
Poly aromatic sodium channel blockers
|
|
MX2010012441A
(es)
|
2008-05-13 |
2010-12-06 |
Novartis Ag |
Derivados de acido 3,5-diamino-6-cloro-pirazin-2-carboxilico y su uso como bloqueadores del canal de sodio epitelial para el tratamiento de enfermedades de las vias respiratorias.
|
|
KR20110040818A
(ko)
|
2008-06-10 |
2011-04-20 |
노파르티스 아게 |
상피 나트륨 채널 차단제로서의 피라진 유도체
|
|
WO2011028740A1
(en)
|
2009-09-03 |
2011-03-10 |
Glaxo Group Limited |
ENaC BLOCKERS
|
|
WO2011079087A1
(en)
|
2009-12-23 |
2011-06-30 |
Glaxo Group Limited |
Enac blockers
|
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
|
US8372845B2
(en)
|
2010-09-17 |
2013-02-12 |
Novartis Ag |
Pyrazine derivatives as enac blockers
|
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
|
NO2773633T3
(cg-RX-API-DMAC7.html)
|
2011-11-02 |
2017-12-30 |
|
|
|
US8859559B2
(en)
|
2011-12-20 |
2014-10-14 |
Boehringer Ingelheim International Gmbh |
Substituted pyrazines and their use in the treatment of disease
|
|
WO2013181232A2
(en)
|
2012-05-29 |
2013-12-05 |
Michael Ross Johnson |
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
|
|
WO2014044849A1
(en)
|
2012-09-24 |
2014-03-27 |
Boehringer Ingelheim International Gmbh |
Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
|
|
RU2671976C2
(ru)
|
2012-12-17 |
2018-11-08 |
Пэрион Сайенсиз, Инк. |
Соединения 3,5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида
|
|
ES2674665T3
(es)
|
2012-12-17 |
2018-07-03 |
Parion Sciences, Inc. |
Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
|
|
HUE032891T2
(hu)
|
2012-12-17 |
2017-11-28 |
Parion Sciences Inc |
Klórpirazin-karboxamid-származékok nem kielégítõ nyálkahártya-hidratáció által elõsegített megbetegedések kezelésére
|
|
EP2991981B1
(en)
|
2013-04-30 |
2017-03-01 |
Boehringer Ingelheim International GmbH |
Diaminopyrazine compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
|
|
CA2915633A1
(en)
|
2013-07-02 |
2015-01-08 |
The California Institute For Biomedical Research |
Compounds for treatment of cystic fibrosis
|
|
WO2015003958A1
(en)
|
2013-07-08 |
2015-01-15 |
Boehringer Ingelheim International Gmbh |
Amiloride-type compounds as inhibitors in epithelial sodium channels for the treatment of diseases of the lungs and airways
|
|
WO2015007519A1
(en)
|
2013-07-15 |
2015-01-22 |
Boehringer Ingelheim International Gmbh |
Novel benzimidazolium compounds
|
|
EP3022197B1
(en)
|
2013-07-15 |
2017-09-06 |
Boehringer Ingelheim International GmbH |
Novel tetra- and pentasubstituted benzimidazolium compounds
|
|
WO2015007516A1
(en)
|
2013-07-15 |
2015-01-22 |
Boehringer Ingelheim International Gmbh |
Novel 5-substituted benzimidazolium compounds
|
|
EP3030555B1
(en)
|
2013-08-08 |
2019-01-30 |
Boehringer Ingelheim International GmbH |
Novel pyrazine amide compounds
|
|
US9932324B2
(en)
|
2015-01-12 |
2018-04-03 |
Boehringer Ingelheim International Gmbh |
Substituted benzimidazolium compounds useful in the treatment of respiratory diseases
|
|
US10155749B2
(en)
|
2015-01-12 |
2018-12-18 |
Boehringer Ingelheim International Gmbh |
Substituted benzimidazolium compounds useful in the treatment of respiratory diseases
|
|
EP3245200B1
(en)
|
2015-01-12 |
2021-03-10 |
Boehringer Ingelheim International GmbH |
2-(pyrazin-2-ylcarbonylaminomethyl)benzimidazolium compounds as epithelial sodium channel inhibitors
|
|
EP3245202B1
(en)
|
2015-01-12 |
2020-03-11 |
Boehringer Ingelheim International GmbH |
Tetrasubstituted benzimidazolium compounds useful in the treatment of respiratory diseases
|
|
MX2018002006A
(es)
|
2015-08-20 |
2018-06-19 |
Boehringer Ingelheim Int |
Benzamidas apareadas novedosas.
|
|
EP3298022B1
(en)
|
2015-08-20 |
2019-06-05 |
Boehringer Ingelheim International GmbH |
Novel annelated phenoxyacetamides
|
|
GB201610854D0
(en)
*
|
2016-06-21 |
2016-08-03 |
Entpr Therapeutics Ltd |
Compounds
|
|
GB201619694D0
(en)
|
2016-11-22 |
2017-01-04 |
Entpr Therapeutics Ltd |
Compounds
|